Pediatrix Medical Group, Inc. (MD)
Pediatrix Medical Group, Inc. brought in $2B of revenue over the twelve months to September 30, 2026, up 1.9% from a year earlier. Net income was $150.1M, a net margin of 7.7%. At September 30, 2026 it held $311.9M in cash against $577.7M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on October 29, 2026.
Key facts about Pediatrix Medical Group, Inc.
- Net worth
- Pediatrix Medical Group, Inc. has a market value (market cap) of $2.6B at the latest share price, and shareholders' equity of $849.6M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $1.9B (-4.9% year on year), with net income of $165.4M. Over the 12 months to September 30, 2026: revenue $2B, net income $150.1M.
- Cash flow
- In fiscal 2025 operations brought in $271.1M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on October 29, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
- Next earnings report
- Pediatrix Medical Group, Inc.'s next report is expected around February 18, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
What Pediatrix Medical Group, Inc. does
Pediatrix Medical Group, Inc. is registered with the SEC under industry code SIC 8060 (Services-Hospitals). Its shares trade on NYSE under the ticker MD.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $1.9B | $165.4M | $1.94 | n/a |
| 2024 | $2B | -$99.1M | -$1.19 | n/a |
| 2023 | $2B | -$60.4M | -$0.73 | n/a |
| 2022 | $2B | $66.3M | $0.79 | n/a |
| 2021 | $1.9B | $131M | $1.53 | n/a |
| 2020 | $1.7B | -$796.5M | -$9.55 | n/a |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where MD ranks in Health care
Latest SEC filings
What Pediatrix Medical Group, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- October 29, 2026Quarterly report 10-Q · period to September 30, 2026Revenue rose 1.7% to $501.4M versus the same quarter last year; diluted EPS $0.59 versus $0.84.
- October 29, 2026
- September 3, 2026Passive stake (5% or more) SCHEDULE 13G
- September 3, 2026Passive stake (5% or more) SCHEDULE 13G
- September 3, 2026Passive stake changed SCHEDULE 13G/A
- August 4, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 4% to $487.8M versus the same quarter last year; diluted EPS $0.49 versus $0.46.
- August 4, 2026
- July 24, 2026
- July 15, 2026
- July 14, 2026Passive stake (5% or more) SCHEDULE 13G
Insider trades
What the people running Pediatrix Medical Group, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider bought or sold shares on the open market in the last 90 days. The 2 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| September 10, 2026 | Linynsky Laura ADirector | Other change | 6,000 | $160.9K |
| August 14, 2026 | Young Sylvia JeanDirector | Other change | 18,500 | $492.5K |
| August 12, 2026 | Sansone Guy PDirector | Received as pay | 472 | $12.5K |
| August 12, 2026 | Young Sylvia JeanDirector | Received as pay | 472 | $12.5K |
| August 12, 2026 | Rucker Michael A.Director | Received as pay | 472 | $12.5K |
| August 12, 2026 | Linynsky Laura ADirector | Received as pay | 472 | $12.5K |
| August 12, 2026 | Newman Kurt DouglasDirector | Received as pay | 472 | $12.5K |
| August 12, 2026 | Starcher John M. Jr.Director | Received as pay | 472 | $12.5K |
Who owns MD
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Vanguard Portfolio Management13G, passive | 7.55% | September 3, 2026 |
| Vanguard Capital Management13G, passive | 5.15% | September 3, 2026 |
| Dimensional Fund Advisors LP13G, passive | 5.1% | July 14, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 304 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| BlackRock, Inc. | 13,714,275 | +139,902 |
| Vanguard Portfolio Management LLC | 5,985,147 | -168,979 |
| Dimensional Fund Advisors LP | 4,220,311 | +363,396 |
| Vanguard Capital Management LLC | 3,620,040 | -36,281 |
| State Street Corp | 3,533,248 | +154,748 |
| Victory Capital Management Inc | 3,416,913 | -425,020 |
| Wasatch Advisors LP | 2,498,884 | +448,360 |
| Geode Capital Management, LLC | 2,226,028 | +38,061 |
| American Century Companies Inc | 2,192,017 | -1,733,349 |
| Fuller & Thaler Asset Management, Inc. | 1,721,451 | +492,020 |
| Allspring Global Investments Holdings, LLC | 1,618,910 | +643,777 |
| D. E. Shaw & Co., Inc. | 1,613,100 | -95,333 |
| Rockefeller Capital Management L.P. | 1,338,592 | +576,095 |
| Morgan Stanley | 1,328,477 | +77,852 |
| Charles Schwab Investment Management Inc | 1,294,185 | -149,206 |
| Renaissance Technologies LLC | 1,287,300 | -245,000 |
| Invesco Ltd. | 1,173,609 | +251,432 |
| Public Sector Pension Investment Board | 987,860 | +566,451 |
| Northern Trust Corp | 934,307 | +34,037 |
| Royce & Associates LP | 914,348 | +235,578 |
Insiders
13 insiders reported holding 1,261,284 shares in total, about $39.9M at the last price.
| Holder | Shares |
|---|---|
| Ordan Mark SChief Executive Officer, Director | 410,884 |
| Moore Mary Ann EEVP, GC, Chief Admin Off & Sec | 189,890111,831 held indirectly |
| Neeb Don GregoryEVP, Chief Invest & Strategy | 137,231 |
| Rossi Kasandra HEVP, CFO and Treasurer | 101,399 |
| Sansone Guy PDirector | 87,416 |
| McEachin ThomasDirector | 73,74166,073 held indirectly |
| Starcher John M. Jr.Director | 73,732 |
| Rucker Michael A.Director | 66,769 |
| Linynsky Laura ADirector | 33,900 |
| Young Sylvia JeanDirector | 29,786 |
Questions about MD
What does Pediatrix Medical Group, Inc. do?
Pediatrix Medical Group, Inc. is a company in the Health care sector, listed on NYSE as MD. Its shares trade on NYSE under the ticker MD.
What is Pediatrix Medical Group, Inc.'s net worth?
Pediatrix Medical Group, Inc. has a market value (market cap) of $2.6B at the latest share price, and shareholders' equity of $849.6M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Pediatrix Medical Group, Inc. profitable?
Yes. Over the twelve months to September 30, 2026 it reported net income of $150.1M on revenue of $2B, a net margin of 7.7%.
How much revenue does Pediatrix Medical Group, Inc. make?
Over the twelve months to September 30, 2026 Pediatrix Medical Group, Inc. reported revenue of $2B. That is 1.9% more than a year earlier.
When did Pediatrix Medical Group, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on October 29, 2026. It covers the period to September 30, 2026.
When is Pediatrix Medical Group, Inc.'s next earnings report?
Pediatrix Medical Group, Inc.'s next report is expected around February 18, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare MD with
Follow MD
Get an email when Pediatrix Medical Group, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Pediatrix Medical Group, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.